共 50 条
- [31] Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for biological relapse (BR) after radical prostatectomy (RP): Results of the GETUG-AFU 16 phase III randomized trial-NCT00423475.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Carrie, ChristianHasbini, AliDe Laroche, GuyHabibian, MurielRichaud, PierreGuerif, StephaneLatorzeff, IgorSupiot, StephaneBosset, MathieuLagrange, Jean LeonBeckendorf, VeroniqueLesaunier, FrancoisDubray, BernardWagner, Jean PhilippeN'Guyen, T. D.Suchaud, Jean-PhilippeCrehange, GillesBarbier, NicolasRuffion, AlainDussart, Sophie
- [32] Short-Term Androgen Deprivation Therapy and High -Dose Radiotherapy in Intermediate- and High -Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III TrialINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S4 - S5Demogeot, N.Sargos, P.Sahki, N.Guerif, S.De Crevoisier, R.Calais, G.Hannoun-Levi, J. M.Bouche, G.Hennequin, C.Cretin, J.Belkacemi, Y.Khalifa, J.Azria, D.Bauer, N.Pommier, P.Pommier, P.Simon, J. M.Leger, C.Beckendorf, V.Dubray, B. M.Supiot, S.
- [33] Adding radiotherapy to androgen deprivation therapy in men with node-positive prostate cancer after radical prostatectomy A meta-analysisMEDICINE, 2020, 99 (10) : E19153Guo, LijuanZhu, ZhaoweiZhang, Xuepei
- [35] SURVIVAL ANALYSIS OF A RANDOMIZED PHASE III TRIAL COMPARING ANDROGEN DEPRIVATION THERAPY (ADT) PLUS DOCETAXEL VERSUS ADT ALONE IN HORMONE-SENSITIVE METASTATIC PROSTATE CANCER (GETUG-AFU 15/0403)ANNALS OF ONCOLOGY, 2012, 23 : 294 - 294Gravis, G.Fizazi, K.Lobbedez, F. JolyOudard, S.Priou, F.Latorzeff, I.Delva, R.Krakowski, I.Laguerre, B.Rolland, F.Theodore, C.Deplanque, G.Ferrero, J. M.Pouessel, D.Mourey, L.Beuzeboc, P.Zanetta, S.Esterni, B.Habibian, M.Soulie, M.
- [36] Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate CancerEUROPEAN UROLOGY OPEN SCIENCE, 2022, 41 : 63 - 73Gongora, MagdalenaStranne, JohanJohansson, EvaBottai, MatteoKarlsson, Camilla ThellenbergBrasso, KlausHansen, SteinbjornJakobsen, HenrikJaderling, FredrikLindberg, HenrietteLilleby, WolfgangPetersen, Peter MeidahlMirtti, TuomasOlsson, MatsRannikko, AnttiRoder, Martin AndreasVincent, Per HenrikAkre, Olof
- [37] Combination of adjuvant radiotherapy and androgen deprivation therapy after radical prostatectomy in high risk prostate cancer patients - results from retrospective analysisJOURNAL OF BUON, 2015, 20 (04): : 1061 - 1067Omrcen, TomislavHrepic, DarioJelavic, Tihana BoraskaVrdoljak, Eduard
- [38] Salvage Radiotherapy Versus Hormone Therapy for Prostate -specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open -label, Phase 3 Trial (JCOG0401)EUROPEAN UROLOGY, 2020, 77 (06) : 689 - 698Yokomizo, AkiraWakabayashi, MasashiSatoh, TakefumiHashine, KatsuyoshiInoue, TakahiroFujimoto, KiyohideEgawa, ShinHabuchi, TomonoriKawashima, KiyotakaIshizuka, OsamuShinohara, NobuoSugimoto, MikioYoshino, YasushiNihei, KeijiFukuda, HaruhikoTobisu, Ken-ichiKakehi, YoshiyukiNaito, Seiji
- [39] Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 TrialEUROPEAN UROLOGY, 2012, 62 (02) : 213 - 219Mottet, NicolasPeneau, MichelMazeron, Jean-JacquesMolinie, VincentRichaud, Pierre
- [40] Phase 2, multicenter, randomized study of salvage radiation therapy plus /- metformin for recurrent prostate cancer after radical prostatectomy (SAKK 08/15-GETUG-AFU 34 PROMET trial).JOURNAL OF CLINICAL ONCOLOGY, 2023, 41Dal Pra, AlanSupiot, StephaneGysel, KatrinZilli, ThomasCathomas, RichardReynaud, ThomasPommier, PascalPutora, Paul MartinBosetti, Davide GiovanniGuckenberger, MatthiasHildebrandt, GuidoChiquet, SabrinaBrihoum, MeryemPapachristofilou, AlexandrosHayoz, StefanieGhadjar, PirusZwahlen, Daniel RudolfGillessen, SilkeOmlin, Aurelius GabrielAebersold, Daniel M.